Green light for Janssen Tremfya in the US

14th July 2017 Uncategorised 0

US regulators have issued a green light for Janssen Biotech’s new biologic Tremfya to treat moderate to severe plaque psoriasis.

More: Green light for Janssen Tremfya in the US
Source: News